Login / Signup

CAR-T therapy bridging to allogeneic HSCT provides durable molecular remission of Ph+ mixed phenotype acute leukaemia with minimal residual disease.

Danqing KongChangju QuHai-Ping DaiZheng LiJia YinSuning ChenLiqing KangGuanghua ChenMingqing ZhuLei YuDepei WuXiaowen Tang
Published in: British journal of haematology (2020)
Keyphrases
  • hematopoietic stem cell
  • stem cell transplantation
  • liver failure
  • respiratory failure
  • bone marrow
  • drug induced
  • aortic dissection
  • disease activity
  • ulcerative colitis
  • high dose
  • hepatitis b virus
  • stem cells